Corvus Pharmaceuticals(CRVS) ZACKS·2024-11-15 14:50Core Viewpoint - The article emphasizes the importance of identifying and maintaining trends in short-term investing, highlighting that sound fundamentals and positive earnings estimates are crucial for sustaining momentum in stocks [1]. Group 1: Recent Price Strength Screen - The "Recent Price Strength" screen is a unique short-term trading strategy that helps identify stocks with strong fundamentals capable of maintaining an uptrend [2]. - Stocks that pass this screen are typically trading in the upper portion of their 52-week high-low range, indicating bullish sentiment [2]. Group 2: Corvus Pharmaceuticals (CRVS) - Corvus Pharmaceuticals is highlighted as a strong candidate for trend investors, having experienced a price increase of 105.3% over the past 12 weeks, indicating investor confidence in its potential upside [3]. - The stock has also seen an 18.2% price increase over the last four weeks, suggesting that the upward trend is still intact [4]. - Currently, CRVS is trading at 83% of its 52-week high-low range, indicating a potential breakout opportunity [4]. Group 3: Fundamental Strength - CRVS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, which are critical for near-term price movements [5]. - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term performance [6]. Group 4: Additional Opportunities - Besides CRVS, there are several other stocks that meet the criteria of the "Recent Price Strength" screen, suggesting further investment opportunities [7]. - The article encourages exploring over 45 Zacks Premium Screens tailored to different investing styles to identify potential winning stocks [7].